A clinical study for availability of algorism to control of anemia of hemodialysis patients

A clinical study for availability of algorism to control of anemia of hemodialysis patients - Algorism study for anemia of HD patients

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000006023

Enrollment

100

Registered

2011-08-01

Start date

2012-04-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

renal anemia

Interventions

algorism

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients treated with erythropoietin agent for more than 6 months under dialysis treatment

Exclusion criteria

Exclusion criteria: patients with bleeding tendency

Design outcomes

Primary

Measure	Time frame
compliance rates for target and hemoglobin variability	—

Secondary

Measure	Time frame
doses of erythropetin administration	—

Countries

Japan

Contacts

Public ContactShinichi Nishi

Kobe University Graduate School of Medicine Division of Nephrology and Kidney Center

snishi@med.kobe-u.ac.jp078-382-6500

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026